A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma

OBJECTIVE: The purpose of this study was to assess the efficacy and tolerability of a paclitaxel, carboplatin and metformin regimen in the first-line treatment of advanced-stage ovarian, fallopian tube, and primary peritoneal carcinoma. METHODS: Eligible subjects underwent surgery and 6 cycles of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Micha, John P., Rettenmaier, Mark A., Bohart, Randy D., Goldstein, Bram H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995875/
https://www.ncbi.nlm.nih.gov/pubmed/36509462
http://dx.doi.org/10.3802/jgo.2023.34.e15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995875/
https://www.ncbi.nlm.nih.gov/pubmed/36509462
http://dx.doi.org/10.3802/jgo.2023.34.e15

Ejemplares similares